Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Cagrilintide used for the treatment of obesity and type 2 diabetes The most intensive medical obesity therapy in the pipeline is retatrutide. Retatrutide is the "triple G," a glucose dependent insulinotropic polypeptide (GIP), glucagon like peptide 1 (GLP 1), and glucagon receptor agonist. It has demonstrated robust blood Cagrilintide + Semaglutide Blend (5mg + 5mg) HGH Peptides Lab Factory Direct